Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 30Gastrointestinal 23Thoracic 21Other solid neoplasm 15Genitourinary 14Other hematologic neoplasm 12Head & Neck 12Gynecologic 10Tumor-Agnostic 9Dermatologic 6Lymphoid 5Plasma cell 4Sarcoma 2Other 2CNS 2Other neoplasm 1Myeloid 1Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 1

Interventions

Eating 5Standard of Care 4Radiofrequency Ablation 4Exercise 4Surgical Procedures, Operative 3Radiosurgery 3Endoscopic Mucosal Resection 3Adrenalectomy 3lutetium Lu 177 dotatate 2Yoga 2Saline Solution 2Robotic Surgical Procedures 2Resistance Training 2Proton Therapy 2Propofol 2Palliative Care 2Octreotide 2Magnetic Resonance Imaging 2Lutetium-177 2Liquid Biopsy 2Interviews as Topic 2Hydrocortisone 2Diet, Mediterranean 2Diet 2Desflurane 2Data Collection 2Conversion to Open Surgery 2Control Groups 2Calcium 23-Iodobenzylguanidine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Practice Guidelines as Topic × Endocrine × Clear all
NCT04032106 2025-03-14

HPV Vaccine Intervention for Young Sexual Minority Men

Ohio State University Comprehensive Cancer Center

Phase NA Completed
1,227 enrolled 8 charts
Endocrine

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡